Approval setback for EpiPen alternative puts spotlight on common anti-competition tactic
Americans who suffer severe allergic reactions won’t have alternatives to auto-injectors like the EpiPen for a while longer. In a surprise move, the Food and
Americans who suffer severe allergic reactions won’t have alternatives to auto-injectors like the EpiPen for a while longer. In a surprise move, the Food and
WASHINGTON — Republicans and Democrats fought it out over Medicare drug price negotiation Wednesday at a House hearing, with the former accusing the latter of
WASHINGTON — Roughly three-quarters of states have legalized marijuana either for medical or recreational use, but for years, cannabis users have been barred from getting
This has been a busy quarter for the psychedelic industry, particularly Lucy Scientific Discovery Inc. The company has announced three acquisitions in the past three
For the fourth time this year, Novartis has been reprimanded by a U.K. trade group for misleading promotional efforts for its biggest-selling drug and, in
The University of Michigan is among 13 institutions that will receive funding from the Centers for Disease Control and Prevention to be part of a
The Eunice Kennedy Shriver National Institute of Child Health and Human Development awarded $3.1 million to the University of Arkansas to study a spectrum of
A trial of a preventive HIV vaccine candidate has begun enrollment in the United States and South Africa.
As cities brace for a confluence of flu, COVID-19, pneumonia, and RSV infections this fall, the American Thoracic Society announced that five new health systems
A new longitudinal study published online in the International Journal of Chronic Obstructive Pulmonary Disease found that older adults with COPD had a heightened risk